Progen Co., Ltd. (XKON:296160)
South Korea · Delayed Price · Currency is KRW 2,045.00
0.00 (0.00%)
At close: Oct 23, 2026
Progen Market Cap
Progen has a market cap or net worth of 31.44 billion as of October 23, 2026. It is the 35,559th most valuable company in the world and the 2,116th biggest in South Korea. Its market cap has decreased by 66.91% in one year.
Market Cap
31.44B
Enterprise Value
n/a
Revenue
450.00M
Global Rank
Country Rank
#2,116 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 15, 2023, Progen's market cap has decreased from 46.33B to 31.44B, a decrease of -32.13%. That is a compound annual growth rate of -12.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 31.44B | -72.88% |
| Dec 30, 2025 | 115.93B | 28.30% |
| Dec 30, 2024 | 90.36B | 9.39% |
| Dec 28, 2023 | 82.60B | 78.30% |
| Nov 15, 2023 | 46.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NovMetaPharma | 49.31B |
| J2KBIO | 49.18B |
| QuadMedicine | 46.73B |
| Parataxis Korea | 44.13B |
| Epibiotech | 43.83B |
| HLB Pep | 39.57B |
| Quratis | 39.29B |
| Kainos Medicine | 35.56B |